Stocksigma LogoStocksigma Logo

Bharat Parenterals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 13,628 (+110.9% YoY | +45.4% QoQ) ■ EBITDA: 2,358 (+2762.5% YoY | +176.3% QoQ) ■ EBITDA Margin (%): 17.3 (+1603 bps YoY | +820 bps QoQ) ■ PAT

Bharat Parenterals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Bharat Parenterals Ltd · Outcome · 29 Oct 2026, 10:25 pm

Bharat Parenterals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 13,628 (+110.9% YoY | +45.4% QoQ) ■ EBITDA: 2,358 (+2762.5% YoY | +176.3% QoQ) ■ EBITDA Margin (%): 17.3 (+1603 bps YoY | +820 bps QoQ) ■ PAT: 942 (Loss to Profit YoY | +834.4% QoQ) ■ EPS (INR): 17.2 (Loss to Profit YoY | Loss to Profit QoQ)

Original exchange filing (PDF)

More announcements from Bharat Parenterals Ltd

All Bharat Parenterals Ltd announcements